RoukenBio Launches New Brand Identity and Completes Phase 2 Expansion of Discovery Centre in Scotland

  RoukenBio, the Collaborative Research Organisation (CRO) formerly known as Antibody Analytics, has today announced completion of the phase 2 expans...

October 04, 2024 | Friday | News
Amira Hovione and Zerion Pharma Expand Partnership to Accelerate Development of Dispersome® Technology

Hovione Farmaciência, S.A.(“HOVIONE”) and Zerion Pharma A/S (“ZERION”) today announced that they have expanded their part...

October 04, 2024 | Friday | News
Oncocyte's GraftAssure™ Assay Adopted by Top U.S. and German Transplant Hospitals, Progresses Toward FDA Submission

GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volume Company clears first stage...

October 03, 2024 | Thursday | News
Citryll Launches Pioneering Collaboration with Dutch Rheumatology Experts to Advance NET-Targeting Therapies for Rheumatoid Arthritis

Learnings will be used in the clinical development programs of NET-targeting therapies such as Citryll’s lead anti-inflammatory candidate CIT-013 ...

October 03, 2024 | Thursday | News
Enara Bio Secures $32.5 Million in Series B Financing, Co-Led by Pfizer Ventures and M Ventures

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapi...

October 03, 2024 | Thursday | News
IASO Biotherapeutics and Chinese Experts Explore Collaboration with Brazil on Cutting-Edge Cancer Therapies

On the eve of the International Myeloma Society (IMS) Annual Meeting, Dr. Yongke Zhang, Chief Scientific Officer of IASO Biotherapeutics (IASO Bio), along ...

September 30, 2024 | Monday | News
SIFI Secures European Patent for Innovative Polihexanide Formulation in Germany Eye Infection Treatment

The company's intellectual property ("IP") covers the formulation and method of use of polihexanide in the treatment of acanthamoeba keratitis and fung...

September 30, 2024 | Monday | News
Takara Bio Europe Launches Shasta™ Single-Cell System, Advancing High-Throughput Oncology Biomarker Discovery

Takara Bio Europe, a wholly owned subsidiary of Takara Bio Inc., announces the launch of the Shasta™ Single-Cell System at the 2024 Human Cell A...

September 27, 2024 | Friday | News
QIAGEN Launches PAXgene Urine Liquid Biopsy Set, Advancing Non-Invasive cfDNA Collection and Stabilization

PAXgene Urine Liquid Biopsy Set with collection cup and a nucleic acid stabilizing tube enables non-invasive sample collection and direct cell-free DNA sta...

September 26, 2024 | Thursday | News
Roche Announces Positive Phase III Results for Gazyva/Gazyvaro in Lupus Nephritis, Demonstrating Superiority Over Standard Therapy Alone

Roche announced positive topline results from the Phase III REGENCY study, which evaluated Gazyva®/Gazyvaro® (obinutuzumab) in people with active...

September 26, 2024 | Thursday | News
Ascend Strengthens Global Gene Therapy Support with New Multi-Million Dollar Investments in Technology and Flexible Capacity

Continued Investment in Technology & Flexible Capacity, Including New Fill/Finish Capabilities, Fortify the Global Gene Therapy Support Offer at Ascend...

September 25, 2024 | Wednesday | News
Agarose Bead Technologies Completes Major Expansion of Spanish Facility to Meet Global Demand for Pharmaceutical Resins

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins, proudly announces the completion of a major expansion at its faci...

September 25, 2024 | Wednesday | News
Metabolomics Diagnostics Develops PrePsia, an Innovative Test to Predict Preeclampsia Risk in Early Pregnancy

-Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately predict t...

September 25, 2024 | Wednesday | News
European Commission Approves Junshi Biosciences' Toripalimab for Two Key Cancer Indications

Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of nov...

September 25, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close